Results 131 to 140 of about 69,085 (277)

Laser and radiofrequency for treating genitourinary syndrome of menopause in breast cancer survivors: A systematic review of randomized controlled trial

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 173, Issue 1, Page 99-108, April 2026.
Abstract Background Breast cancer survivors (BCS) often experience more severe symptoms of genitourinary syndrome of menopause (GSM). As estrogen‐based hormonal therapy is generally avoided in BCS, physical energy methods may offer promising non‐hormonal alternatives.
Nicoli Serquiz   +7 more
wiley   +1 more source

Selumetinib as an Effective Therapy of Histiocytic Sarcoma Evolving From a B‐Cell Acute Lymphoblastic Leukaemia

open access: yeseJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Introduction Histiocytic sarcoma (HS) is a rare neoplasm derived from non‐Langerhans histiocytic cells, exceptionally arising from B‐ALL. Methods We present the case of a child with high‐risk B‐ALL with PAX5 P80R mutation. Results Despite initial remission, a chemoresistant paravertebral mass was identified as HS.
Laetitia Largeaud   +12 more
wiley   +1 more source

Determining the Survival Impact and Cost‐Effectiveness of Multi‐Gene Panel Sequencing in Metastatic Colorectal Cancer With Super Learning Approaches

open access: yesHealth Services Research, Volume 61, Issue 2, April 2026.
ABSTRACTObjectiveTo determine the effectiveness and cost‐effectiveness of multi‐gene panel sequencing compared to single‐gene KRAS testing for metastatic colorectal cancer (mCRC).Study Setting and DesignBritish Columbia, Canada (BC) is a provincial single‐payer public healthcare system, and it was the first province to publicly reimburse multi‐gene ...
Emanuel Krebs   +4 more
wiley   +1 more source

Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular features

open access: yesHistopathology, Volume 88, Issue 5, Page 1044-1050, April 2026.
Papillary renal cell carcinoma (pRCC) accounts for 15%–20% of RCC cases and is the second most common histologic subtype of RCC. In contrast to other common RCC subtypes, there continues to be ongoing debate about how to classify RCCs with papillary architecture and eosinophilic cytoplasm, given the heterogeneity of histologic, IHC and molecular ...
Melissa Yuwono Tjota   +3 more
wiley   +1 more source

Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report [PDF]

open access: yes, 2019
Callebout, Eduard   +7 more
core   +2 more sources

Impact of melanoma histological regression on first‐line immunotherapy response in stage‐IV disease

open access: yes
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Jean‐Baptiste Such   +6 more
wiley   +1 more source

Use of a Cytobrush for Sampling the Ear Canal of Dogs With Otitis Externa

open access: yesVeterinary Dermatology, Volume 37, Issue 2, Page 227-235, April 2026.
Cytological examination of the ear canal is essential for evaluating dogs with otitis externa (OE). The conventional sampling method uses a swab. However, the cytobrush (gynaecological cervical brush), already used for cytological collection from other anatomical sites, has not been adequately investigated for this purpose in dogs with OE.
Nicoly Radaeli Atanasio   +3 more
wiley   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

open access: yesMolecular Oncology, Volume 20, Issue 3, Page 629-636, March 2026.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy